Stay updated with breaking news from V Imaging. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Echo findings in heart failure patients with preserved or mildly reduced ejection fraction treated with an atrial shunt shed light on why only certain patients respond to therapy.
Over 1 year after phase 3 studies suggested that delgocitinib cream was safe and effective for chronic hand eczema, extension data indicate that control persists without new safety issues.
In patients who had revascularization after an acute MI and had a preserved EF, long-term beta-blocker use showed no benefit compared with no beta-blockers, in REDUCE-AMI.
In patients with HFpEF and obesity, symptom reduction and weight loss provided by semaglutide extends to those with diabetes, suggest new data from the STEP-HFpEF DM trial.
Use of a microaxial flow pump led to a lower risk of death in patients with STEMI-related cardiogenic shock in the DanGer Shock trial, although with more adverse events.